Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 13, Issue 7, pp. 2128-2135
PubMed
Published By
Print ISSN
Online ISSN
History
- Accepted January 25, 2007
- Received November 27, 2006
- Revision received January 15, 2007
- Published first April 2, 2007.
Copyright & Usage
American Association for Cancer Research
Author Information
- Saifee A. Mullamitha1,
- Nhuan C. Ton1,
- Geoff J.M. Parker3,
- Alan Jackson3,
- Peter J. Julyan2,
- Caleb Roberts3,
- Gio A. Buonaccorsi3,
- Yvonne Watson3,
- Karen Davies3,
- Sue Cheung3,
- Lynn Hope1,
- Juan W. Valle1,
- John A. Radford1,
- Jeremy Lawrance1,
- Mark P. Saunders1,
- Mihaela C. Munteanu4,
- Marian T. Nakada5,
- Jeffrey A. Nemeth5,
- Hugh M. Davis6,
- Qun Jiao6,
- Uma Prabhakar6,
- Zhihui Lang7,
- Robert E. Corringham7,
- Robert A. Beckman7,
- Gordon C. Jayson1 and
- in association with the Biotherapy Development Association
- Authors' Affiliations:1Cancer Research UK and 2Department of Medical Physics, Christie Hospital, Withington; 3Imaging Science and Biomedical Engineering, University of Manchester, Manchester, United Kingdom; and 4Department of Clinical Trial Management, 5Oncology Discovery Research, 6Clinical Pharmacology, and 7Oncology Clinical Research and Development, Centocor Research and Development, Inc., Malvern, Pennsylvania
- Requests for reprints:
Gordon Jayson, Department of Medical Oncology, Christie Hospital, Wilmslow Road, Withington, Manchester M20 4BX, United Kingdom. Phone: 44-161-446-3606; Fax: 44-161-446-8565; E-mail: Gordon.Jayson{at}christie-tr.nwest.nhs.uk.
April 2007
Volume 13, Issue 7
Volume 13, Issue 7
Phase I Evaluation of a Fully Human Anti–αv Integrin Monoclonal Antibody (CNTO 95) in Patients with Advanced Solid Tumors
Jump to section
Advertisement